share_log

Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(1.97%),Deep Track Biotechnology Master Fund, Ltd.(1.97%), etc.

SEC ·  Nov 14 09:47
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more